All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our March Discussion Group addressing ‘Sustainable Synthesis of Therapeutic Oligonucleotides’ brought together an exclusive panel of key opinion leaders to address the market’s growth and future outlook.
Edited by Tia Byer |
21 April 2022
Oligonucleotides
Insight Article
With efficacy, safety, and targetability being the top three challenges facing the nucleotide-based therapeutic industry today, will oligo-based therapies fulfil their potential as a clinical modality?
Edited by Tia Byer |
03 March 2022
Oligonucleotides
Post-Event Report
The first of its kind, the Oligonucleotides: Chemistry & Therapeutics Symposium was a hit. We sat down with an advisory group of leading industry experts to hear their thoughts on the future of the Oligonucleotide drug industry as well as some of its key market trends and challenges.
Edited by Tia Byer |
02 March 2022
Oligonucleotides
Commentary
Oligonucleotides are fast becoming a globally recognised form of therapeutic treatment. But how easy is it to analyse them? Director of AstraZeneca, Tomas Leek takes us through the analytic challenges of the early-stage oligonucleotide characterisation.
Edited by Tia Byer |
01 March 2022
Oligonucleotides
Audio Content
Podcast
We spoke with Xianglin Shi, Principal Scientist at Biogen to find out what key milestones have contributed to this growth. This episode is a fantastic 10 minute insight for you to also hear what challenges face oligonucleotide synthesis and a look to what the future holds for this exciting industry.
01 March 2021
Oligonucleotides
Audio Content
Podcast
The challenges of using oligonucleotides for therapeutic applications in oncology is an interesting subject. We spoke with Charles Sinclair, Senior Principal Scientist, Bristol-Myers Squibb to find more. This episode is also a fantastic insight for you to hear what the future holds for oligonucleotides.
05 February 2021
Oligonucleotides

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login